528 related articles for article (PubMed ID: 3475395)
1. Effect of aspirin on experimental diabetic nephropathy.
Moel DI; Safirstein RL; McEvoy RC; Hsueh W
J Lab Clin Med; 1987 Sep; 110(3):300-7. PubMed ID: 3475395
[TBL] [Abstract][Full Text] [Related]
2. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Ekberg K; Isaksson B; Eriksson L; Wahren J; Sjöquist M
Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
[TBL] [Abstract][Full Text] [Related]
3. Role for local prostaglandin and thromboxane production in the regulation of glomerular filtration rate in the rat with streptozocin-induced diabetes.
Craven PA; DeRubertis FR
J Lab Clin Med; 1989 Jun; 113(6):674-81. PubMed ID: 2525167
[TBL] [Abstract][Full Text] [Related]
4. Disparate effects of castration on renal structure and function in the streptozotocin diabetic rat.
Bach LA; Cooper ME; Vranes D; Allen TJ; Rumble J; Jerums G
Diabetes Res; 1994; 27(1):27-38. PubMed ID: 7648794
[TBL] [Abstract][Full Text] [Related]
5. C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats.
Samnegård B; Jacobson SH; Johansson BL; Ekberg K; Isaksson B; Wahren J; Sjöquist M
Nephrol Dial Transplant; 2004 Jun; 19(6):1385-91. PubMed ID: 15004258
[TBL] [Abstract][Full Text] [Related]
6. Determinants of glomerular filtration and plasma flow in experimental diabetic rats.
Michels LD; Davidman M; Keane WF
J Lab Clin Med; 1981 Dec; 98(6):869-85. PubMed ID: 7031154
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
Perico N; Amuchastegui CS; Malanchini B; Bertani T; Remuzzi G
Exp Nephrol; 1994; 2(4):220-8. PubMed ID: 8069658
[TBL] [Abstract][Full Text] [Related]
8. Effect of experimental diabetes on glomerular filtration rate and glomerular prostanoid production in the rat.
Kirschenbaum MA; Chaudhari A
Miner Electrolyte Metab; 1986; 12(5-6):352-5. PubMed ID: 3807832
[TBL] [Abstract][Full Text] [Related]
9. [The effect of temocapril, an angiotensin-converting enzyme inhibitor with preferential biliary excretion, on experimental diabetic nephropathy].
Yanagisawa Y
Nihon Jinzo Gakkai Shi; 1994 Oct; 36(10):1095-102. PubMed ID: 7815741
[TBL] [Abstract][Full Text] [Related]
10. An analysis of renal nitric oxide contribution to hyperfiltration in diabetic rats.
Schwartz D; Schwartz IF; Blantz RC
J Lab Clin Med; 2001 Feb; 137(2):107-14. PubMed ID: 11174467
[TBL] [Abstract][Full Text] [Related]
11. Effects of p38 mitogen-activated protein kinase inhibition on blood pressure, renal hemodynamics, and renal vascular reactivity in normal and diabetic rats.
Komers R; Schutzer W; Xue H; Oyama TT; Lindsley JN; Anderson S
Transl Res; 2007 Dec; 150(6):343-9. PubMed ID: 18022596
[TBL] [Abstract][Full Text] [Related]
12. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
[TBL] [Abstract][Full Text] [Related]
13. The C-peptide fragment EVARQ reduces glomerular hyperfiltration in streptozotocin-induced diabetic rats.
Nordquist L; Moe E; Sjöquist M
Diabetes Metab Res Rev; 2007 Jul; 23(5):400-5. PubMed ID: 17103462
[TBL] [Abstract][Full Text] [Related]
14. Healing of chronic gastric ulcers in diabetic rats treated with native aspirin, nitric oxide (NO)-derivative of aspirin and cyclooxygenase (COX)-2 inhibitor.
Brzozowska I; Targosz A; Sliwowski Z; Kwiecien S; Drozdowicz D; Pajdo R; Konturek PC; Brzozowski T; Pawlik M; Konturek SJ; Pawlik WW; Hahn EG
J Physiol Pharmacol; 2004 Dec; 55(4):773-90. PubMed ID: 15613743
[TBL] [Abstract][Full Text] [Related]
15. [Prevention by L-dopa of early renal consequences of diabetes induced by streptozocin in rats].
Vailly B; Barthelmebs M; Velly J; Grima M; Imbs JL
Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1259-62. PubMed ID: 2148079
[TBL] [Abstract][Full Text] [Related]
16. Effect of KATP channel blocker U37883A on renal function in experimental diabetes mellitus in rats.
Vallon V; Albinus M; Blach D
J Pharmacol Exp Ther; 1998 Sep; 286(3):1215-21. PubMed ID: 9732381
[TBL] [Abstract][Full Text] [Related]
17. The effects of dietary cholesterol on experimental diabetic nephropathy.
Cooper ME; Vranes D; Vranes DA; Allen TJ; Panagiotopoulos S; Komers R; Jerums G
Diabetes Res; 1993; 22(4):159-69. PubMed ID: 8070237
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition by aspirin of platelet thromboxane and renal prostaglandins in the rat.
Livio M; Benigni A; Zoja C; Begnis R; Morelli C; Rossini M; Garattini S; Remuzzi G
J Pharmacol Exp Ther; 1989 Jan; 248(1):334-41. PubMed ID: 2492341
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic roles of thromboxane A2 and prostaglandin E2 in glomerulonephritis.
Stork JE; Dunn MJ
J Pharmacol Exp Ther; 1985 Jun; 233(3):672-8. PubMed ID: 3859644
[TBL] [Abstract][Full Text] [Related]
20. Effects of angiotensin-converting enzyme inhibition in diabetic rats with reduced renal function.
Geiger H; Bahner U; Vaaben W; Dammrich J; Heidland A; Luft FC
J Lab Clin Med; 1992 Dec; 120(6):861-8. PubMed ID: 1453108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
